These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 15058363

  • 21. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [Abstract] [Full Text] [Related]

  • 22. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
    Zoufaly A, Stellbrink HJ, Heiden MA, Kollan C, Hoffmann C, van Lunzen J, Hamouda O, ClinSurv Study Group.
    J Infect Dis; 2009 Jul 01; 200(1):79-87. PubMed ID: 19476437
    [Abstract] [Full Text] [Related]

  • 23. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
    Jarrin I, Lumbreras B, Ferreros I, Pérez-Hoyos S, Hurtado I, Hernández-Aguado I.
    Int J Epidemiol; 2007 Feb 01; 36(1):187-94. PubMed ID: 17085455
    [Abstract] [Full Text] [Related]

  • 24. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
    Santagostino E, Gringeri A, Cultraro D, Tradati F, Siracusano L, Marinoni A, Mannucci PM.
    Cell Mol Biol (Noisy-le-grand); 1995 May 01; 41(3):371-80. PubMed ID: 7580830
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
    Muga R, Ferreros I, Langohr K, de Olalla PG, Del Romero J, Quintana M, Alastrue I, Belda J, Tor J, Pérez-Hoyos S, Del Amo J, Spanish Multicenter Study Group of Seroconverters (GEMES).
    AIDS; 2007 Nov 30; 21(18):2521-7. PubMed ID: 18025889
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E, De Silvestri A, Boschi A, Tinelli C.
    AIDS Rev; 2008 Nov 30; 10(4):236-44. PubMed ID: 19092979
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1070-6. PubMed ID: 15265968
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
    Lohse N, Kronborg G, Gerstoft J, Larsen CS, Pedersen G, Pedersen C, Sørensen HT, Obel N.
    Clin Infect Dis; 2006 Jan 01; 42(1):136-44. PubMed ID: 16323104
    [Abstract] [Full Text] [Related]

  • 36. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A, Larussa D, Cingolani A, Lorenzini P, Bossolasco S, Finazzi MG, Bongiovanni M, Guaraldi G, Grisetti S, Vigo B, Gigli B, Mariano A, Dalle Nogare ER, De Marco M, Moretti F, Corsi P, Abrescia N, Rellecati P, Castagna A, Mussini C, Ammassari A, Cinque P, d'Arminio Monforte A, Italian Registry Investigative NeuroAIDS.
    Clin Infect Dis; 2004 Dec 01; 39(11):1681-91. PubMed ID: 15578371
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.